seed
Stage
1
Investors
About
Cornea Sense develops a medical diagnostic device that measures ocular surface hydration to assist eye doctors in diagnosing and monitoring ocular and metabolic diseases such as dry eye disease and diabetes. The company has a functional prototype validated on phantom models and is in the process of clinical validation and human-eye measurements.
Explore Cornea Sense's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.